Literature DB >> 23201615

Still seeking an effective "one-two" malaria vaccine punch.

Joseph D Smith1, Brandon K Sack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23201615      PMCID: PMC3519999          DOI: 10.1038/mt.2012.241

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  16 in total

1.  The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria.

Authors:  Morris O Makobongo; George Riding; Huji Xu; Chakrit Hirunpetcharat; Dianne Keough; John de Jersey; Peter Willadsen; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-19       Impact factor: 11.205

2.  Immunology. Another shot at a malaria vaccine.

Authors:  Stefan H I Kappe; Sebastian A Mikolajczak
Journal:  Science       Date:  2011-10-28       Impact factor: 47.728

3.  Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.

Authors:  J E Epstein; K Tewari; K E Lyke; B K L Sim; P F Billingsley; M B Laurens; A Gunasekera; S Chakravarty; E R James; M Sedegah; A Richman; S Velmurugan; S Reyes; M Li; K Tucker; A Ahumada; A J Ruben; T Li; R Stafford; A G Eappen; C Tamminga; J W Bennett; C F Ockenhouse; J R Murphy; J Komisar; N Thomas; M Loyevsky; A Birkett; C V Plowe; C Loucq; R Edelman; T L Richie; R A Seder; S L Hoffman
Journal:  Science       Date:  2011-09-08       Impact factor: 47.728

4.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

5.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

6.  Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage.

Authors:  Elodie Belnoue; Tatiana Voza; Fabio T M Costa; Anne Charlotte Grüner; Marjorie Mauduit; Daniela Santoro Rosa; Nadya Depinay; Michèle Kayibanda; Ana Margarida Vigário; Dominique Mazier; Georges Snounou; Photini Sinnis; Laurent Rénia
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.

Authors:  D Herrington; J Davis; E Nardin; M Beier; J Cortese; H Eddy; G Losonsky; M Hollingdale; M Sztein; M Levine
Journal:  Am J Trop Med Hyg       Date:  1991-11       Impact factor: 2.345

8.  The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody.

Authors:  Alexander D Douglas; Andrew R Williams; Joseph J Illingworth; Gathoni Kamuyu; Sumi Biswas; Anna L Goodman; David H Wyllie; Cécile Crosnier; Kazutoyo Miura; Gavin J Wright; Carole A Long; Faith H Osier; Kevin Marsh; Alison V Turner; Adrian V S Hill; Simon J Draper
Journal:  Nat Commun       Date:  2011-12-20       Impact factor: 14.919

9.  Effective induction of high-titer antibodies by viral vector vaccines.

Authors:  Simon J Draper; Anne C Moore; Anna L Goodman; Carole A Long; Anthony A Holder; Sarah C Gilbert; Fergal Hill; Adrian V S Hill
Journal:  Nat Med       Date:  2008-07-27       Impact factor: 53.440

10.  ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans.

Authors:  Susanne H Sheehy; Christopher J A Duncan; Sean C Elias; Prateek Choudhary; Sumi Biswas; Fenella D Halstead; Katharine A Collins; Nick J Edwards; Alexander D Douglas; Nicholas A Anagnostou; Katie J Ewer; Tom Havelock; Tabitha Mahungu; Carly M Bliss; Kazutoyo Miura; Ian D Poulton; Patrick J Lillie; Richard D Antrobus; Eleanor Berrie; Sarah Moyle; Katherine Gantlett; Stefano Colloca; Riccardo Cortese; Carole A Long; Robert E Sinden; Sarah C Gilbert; Alison M Lawrie; Tom Doherty; Saul N Faust; Alfredo Nicosia; Adrian V S Hill; Simon J Draper
Journal:  Mol Ther       Date:  2012-10-23       Impact factor: 11.454

View more
  1 in total

1.  Layer-by-Layer Delivery of Multiple Antigens Using Trimethyl Chitosan Nanoparticles as a Malaria Vaccine Candidate.

Authors:  Yang Xu; Ziyou Zhou; Brad Brooks; Tammy Ferguson; Judy Obliosca; Jing Huang; Izumi Kaneko; Shiroh Iwanaga; Masao Yuda; Yukiko Tsuji; Huitang Zhang; Christina C Luo; Xunqing Jiang; Xiang-Peng Kong; Moriya Tsuji; Christopher K Tison
Journal:  Front Immunol       Date:  2022-08-17       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.